(Q33770078)

29 July 2017

title

Pharmacokinetics and pharmacodynamics of fluoroquinolones (English)

1 reference

29 July 2017

1 reference

1 reference

Turnidge J

1

1 reference

29 July 2017

publication date

1 January 1999

1 reference

29 July 2017

1 reference

29 July 2017

volume

58 Suppl 2

1 reference

29 July 2017

page(s)

29-36

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-199958002-00006

29 July 2017

exact match

0 references

cites work

Comparative study of pharmacokinetics of two new fluoroquinolones, balofloxacin and grepafloxacin, in elderly subjects

1 reference

12 December 2020

Effect of an antacid containing magnesium and aluminum on absorption, metabolism, and mechanism of renal elimination of pefloxacin in humans

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of oral grepafloxacin in patients with acute bacterial exacerbations of chronic bronchitis

1 reference

12 December 2020

Multiple-dose pharmacokinetics of sparfloxacin and its influence on fecal flora

1 reference

12 December 2020

Comparative study with enoxacin and netilmicin in a pharmacodynamic model to determine importance of ratio of antibiotic peak concentration to MIC for bactericidal activity and emergence of resistance

1 reference

12 December 2020

Interaction study of lomefloxacin and ciprofloxacin with omeprazole and comparative pharmacokinetics

1 reference

12 December 2020

In vitro antimicrobial activity of CP-99433 compared with other fluoroquinolones.

1 reference

12 December 2020

Inhibition of norfloxacin absorption by dairy products

1 reference

12 December 2020

Pharmacokinetics and serum bactericidal titers of ciprofloxacin and ofloxacin following multiple oral doses in healthy volunteers

1 reference

12 December 2020

Multicenter in vitro evaluation of lomefloxacin (NY-198, SC-47111), including tests against nearly 7,000 bacterial isolates and preliminary recommendations for susceptibility testing.

1 reference

12 December 2020

Pharmacodynamics of a fluoroquinolone antimicrobial agent in a neutropenic rat model of Pseudomonas sepsis

1 reference

12 December 2020

Multicenter in vitro comparative study of fluoroquinolones against 25,129 gram-positive and gram-negative clinical isolates.

1 reference

12 December 2020

Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients

1 reference

12 December 2020

Oral bioavailability of trovafloxacin with and without food in healthy volunteers.

1 reference

12 December 2020

Single- and multiple-dose pharmacokinetics of AM-1155, a new 6-fluoro-8-methoxy quinolone, in humans

1 reference

12 December 2020

Absence of age and gender effects on the pharmacokinetics of a single 500-milligram oral dose of levofloxacin in healthy subjects

1 reference

12 December 2020

In-vitro activity of trovafloxacin, a new fluoroquinolone, against recent clinical isolates

1 reference

12 December 2020

Killing and regrowth of bacteria in vitro: a review.

1 reference

12 December 2020

Levofloxacin population pharmacokinetics and creation of a demographic model for prediction of individual drug clearance in patients with serious community-acquired infection.

1 reference

12 December 2020

In vitro antibacterial activity of DU-6859a, a new fluoroquinolone

1 reference

12 December 2020

Pharmacodynamics of levofloxacin: a new paradigm for early clinical trials

1 reference

12 December 2020

In vitro antibacterial activity of Q-35, a new fluoroquinolone

1 reference

12 December 2020

Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men.

1 reference

12 December 2020

In vitro activity of HSR-903, a new quinolone

1 reference

12 December 2020

Effects of aluminum hydroxide and famotidine on bioavailability of tosufloxacin in healthy volunteers

1 reference

12 December 2020

In vitro activity of Bay 12-8039, a new 8-methoxyquinolone

1 reference

12 December 2020

Pharmacokinetics, safety, and tolerability of ascending single doses of moxifloxacin, a new 8-methoxy quinolone, administered to healthy subjects

1 reference

12 December 2020

Effect of gastric acidity on enoxacin absorption

1 reference

12 December 2020

In vitro and in vivo evaluations of LB20304, a new fluoronaphthyridone

1 reference

12 December 2020

Difloxacin metabolism and pharmacokinetics in humans after single oral doses

1 reference

12 December 2020

In vitro antibacterial activity of AM-1155, a novel 6-fluoro-8-methoxy quinolone

1 reference

12 December 2020

In vitro activities of clinafloxacin against contemporary clinical bacterial isolates from 10 North American centers

1 reference

12 December 2020

Pharmacokinetics and tolerance of DU-6859a, a new fluoroquinolone, after single and multiple oral doses in healthy volunteers

1 reference

12 December 2020

Pharmacokinetics of rufloxacin in patients with impaired renal function

1 reference

12 December 2020

In vitro activity of MF 5137, a new potent 6-aminoquinolone

1 reference

12 December 2020

Comparative in vitro activities of a new quinolone, OPC-17116, possessing potent activity against gram-positive bacteria

1 reference

12 December 2020

Pharmacokinetics of ofloxacin after parenteral and oral administration

1 reference

12 December 2020

Pharmacokinetics and inflammatory fluid penetration of clinafloxacin.

1 reference

12 December 2020

Effect of enteral feeding with ensure on oral bioavailabilities of ofloxacin and ciprofloxacin

1 reference

12 December 2020

Effect of sucralfate on absorption of norfloxacin and ofloxacin

1 reference

12 December 2020

The effect of milk consumption on the pharmacokinetics of fleroxacin and ciprofloxacin in healthy volunteers

1 reference

12 December 2020

Pharmacokinetics of grepafloxacin after oral administration of single and repeat doses in healthy young males

1 reference

12 December 2020

10.2165/00003495-199958002-00006

Identifiers

DOI

0 references

Dimensions Publication ID

1000975821

0 references

1 reference